France reports first human Shamonda virus case and death in Lyon

French health authorities reported the first known human case of the Shamonda virus in early October, involving a severely immunocompromised patient in Lyon who died after developing neurological complications.

Key Clinical Takeaways:
• The patient contracted the insect-borne virus, traditionally found in livestock across Africa and Asia, via a midge bite in eastern France.
• Ministries confirmed no public health risk exists for the general population, classifying the fatality as an exceptional case.
• The European Centre for Disease Prevention and Control is monitoring the situation alongside the World Health Organization as investigations continue.

First Human Fatality Confirmed in Lyon

The Shamonda virus, an Orthobunyavirus previously documented solely in animals, claimed its first human life this month, according to French health authorities. The victim was a severely immunocompromised patient hospitalized for a serious underlying medical condition at a hospice in Lyon. Preliminary findings link the patient’s fatal cerebral complications very likely to the viral infection. Health officials emphasized the patient’s weakened immune system left them more vulnerable to the pathogen.

Midge Bites Spread Virus to Livestock Across Europe

The infection originated from a midge bite sustained in eastern France, where the insect vector circulated actively among livestock through the spring and summer months. Higher European temperatures, driven by heatwaves, may have contributed to the virus establishing itself on the continent for the first time this summer. While cattle serve as the primary animal hosts—exhibiting symptoms such as acute diarrhea, fever, lethargy, and a drop in milk production—the virus has also impacted sheep, goats, horses, and alpacas across 14 western European countries.

Ongoing Epidemiological Investigations

Clinical, biological, and epidemiological investigations remain active to determine the exact mechanics of cross-species transmission. Both the World Health Organization and the European Centre for Disease Prevention and Control have received formal notifications regarding the case. No specific vaccine or antiviral medication currently exists for Shamonda disease. French ministries stress that the pathogen poses no broader threat to the general public, characterizing the human fatality as an isolated, exceptional event tied directly to severe underlying immunosuppression.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

More on France: France Launches 2026-2027 Flu and Covid-19 Vaccination Campaign · France braces for 90 demonstrations as Lecornu convenes crisis unit · France: Respiratory Infection Activity at Baseline in Week 41